Weight loss drug maker sinks 25% after new safety data spooks investors

Jun 8, 2026 - 05:50

0 0

Weight loss drug maker sinks 25% after new safety data spooks investors

While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

U.S. and Iran reach deal to end the Mideast war, with agreement set to be signed Friday

U.S. and Iran reach deal to end the Mideast war, with a...

Jun 15, 2026 0 0

A millennial hit financial independence in 3 years using 2 levers and one simple formula

A millennial hit financial independence in 3 years usin...

Jun 15, 2026 0 0

Markets cheer U.S.-Iran agreement, but some investors caution deal is yet to be signed

Markets cheer U.S.-Iran agreement, but some investors c...

Jun 14, 2026 0 0

U.S. and Iran reach peace deal to end the Mideast war, with agreement set to be signed Friday

U.S. and Iran reach peace deal to end the Mideast war, ...

Jun 14, 2026 0 0

SpaceX: To the moon for investors or a bumpy ride? Here's what experts say

SpaceX: To the moon for investors or a bumpy ride? Here...

Jun 15, 2026 0 0

SpaceX gains 6% in premarket after record debut

SpaceX gains 6% in premarket after record debut

Jun 15, 2026 0 0